Reduction in Heart Rate Variability in Autosomal Dominant Polycystic Kidney Disease

Silvia Lai1, Marco Mangiulli2, Adolfo M Perrotta2

  • 1Nephrology Unit, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy, silvia.lai@uniroma1.it.

Insights

Autonomic dysfunction, measured by heart rate variability (HRV), is reduced in autosomal dominant polycystic kidney disease (ADPKD) patients even with mild hypertension. This suggests increased cardiovascular risk in ADPKD patients beyond traditional factors.

Area of Science:

  • Nephrology
  • Cardiology
  • Autonomic Neuroscience

Background:

  • Cardiovascular disease is a primary cause of mortality in Autosomal Dominant Polycystic Kidney Disease (ADPKD).
  • Autonomic dysfunction, assessed via heart rate variability (HRV), is linked to cardiovascular event risk in the general population.

Purpose of the Study:

  • To compare HRV in ADPKD patients with mild hypertension against hypertensive patients with organ damage and healthy controls.
  • To investigate autonomic nervous system function in ADPKD patients.

Main Methods:

  • Enrolled 65 participants: 21 ADPKD patients, 20 hypertensive patients, and 24 healthy controls.
  • Utilized biochemical analysis, clinical evaluation, anthropometric data, intima-media thickness, 24-h ECG Holter monitoring, and echocardiography.

Main Results:

  • No significant HRV differences were observed between ADPKD patients and hypertensive patients.
  • Global autonomic activity (SDNN) was significantly lower in both ADPKD and hypertensive patients compared to controls.
  • Analysis revealed altered sympathovagal balance (LF/HF ratio) and sympathetic (LF) and parasympathetic (HF) activity during day and night in ADPKD and hypertensive patients versus controls.

Conclusions:

  • Reduced HRV and altered sympathovagal balance are present in ADPKD patients with mild hypertension, even without overt organ damage.
  • HRV assessment offers valuable insights into cardiovascular risk in ADPKD patients, complementing traditional risk factors.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
576
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
563
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
416
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
816
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
482
Decreased pulse rate01:14

Decreased pulse rate

Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
850